New Releases from NCBI BookshelfMirikizumab for treating moderately to severely active Crohn’s disease.Mirikizumab for treating moderately to severely active Crohn’s disease.
Post Content
Post Content
Surgical outcomes are worse in people with diabetes, in part, because of the effects of hyperglycaemia, obesity and other comorbidities.
The top priority for research into symptomatic cerebral cavernous malformation (also known as brain cavernoma) is whether to have medical
The Routledge Companion to Literatures and Crisis provides a deep insight into a complex and multi-layered phenomenon. The third decade
Main Study